Paid Clinical Trials in Savannah, GA
As of June 2026, 159 paid clinical trials are recruiting in Savannah, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Savannah offers studies at sites including Memorial Health University Medical Center for conditions such as Major Depressive Disorder, Breast Cancer, Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Savannah
Trials by drug in Savannah
Filter results
159 clinical trials
↓ Download CSVALTO-207 in Adults With Treatment-resistant Depression (TRD)
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
About research studies in Savannah
Savannah has approximately 159 recruiting research studies across a wide range of therapeutic areas. Georgia is home to Emory University Hospital, Winship Cancer Institute, and Children's Healthcare of Atlanta, with active research in oncology, infectious disease, and cardiovascular health.
Top Research Study Locations in Savannah
Researchers run research studies in Savannah, GA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Health University Medical Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Atrial Fibrillation | 42 |
| Lewis Cancer and Research Pavilion at Saint Joseph's/Candler | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 30 |
| Low Country Cancer Care | Malignant Solid Neoplasm, Stage IV Breast Cancer AJCC v6 and v7, Acute Lymphoblastic Leukemia | 7 |
| CenExel iResearch, LLC | Agitation, Alzheimer Disease, Bipolar Disorder | 7 |
| Velocity Clinical Research, Savannah | COVID-19 Infection, COVID-19 SARS-CoV-2 Infection, Clostridioides Difficile Associated Disease | 5 |
| Georgia Skin & Cancer Clinic | Alopecia Areata, Hidradenitis Suppurativa (HS), Atopic Dermatitis | 4 |
| Summit Cancer Care | Advanced Breast Cancer, Advanced Solid Tumors, Breast Cancer | 3 |
| Summit Cancer Care, PC | Breast Cancer, Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions | 3 |
| Velocity Clinical Research - Savannah | Atherosclerotic Cardiovascular Disease, Diabetic Peripheral Neuropathic Pain, Obesity | 3 |
| Aeroallergy Research Laboratory | Atopic Dermatitis, Pruritus, Dermatitis Atopic | 3 |
| Cenexel Iresearch - Savannah | Major Depressive Disorder | 2 |
| Orthopedic Research Foundation | Chronic Pain, Pain | 2 |
| Summit Cancer Care PC | Early Breast Cancer, KRAS G12C Lung Cancer, Non-Small Cell Lung Cancer | 2 |
| Summit Cancer Care-Candler | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Elevated CA15-3 or CEA or CA27-29 | 2 |
| Lewis Cancer and Research Pavilion | Metastatic Breast Cancer, Non Small Cell Lung Cancer | 2 |
| Memorial University Medical Center | Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer | 2 |
| iResearch Savannah | Depressive Disorder, Major, Generalized Anxiety Disorder (GAD) | 2 |
| Aeroallergy Research Laboratories | Chronic Spontaneous Urticaria (CSU) | 1 |
| Atd002 52015 | Atopic Dermatitis | 1 |
| Autobahn | Major Depressive Disorder | 1 |
| Candler Hospital | Breast Cancer | 1 |
| CenExel | Treatment Resistant Depression | 1 |
| CenExel Savannah | Major Depressive Disorder | 1 |
| CenExel iRS (iResearch Savannah) | Major Depressive Disorder | 1 |
| CenExel iResearch | Major Depressive Disorder | 1 |
Active & Upcoming Studies in Savannah (2026)
Recruiting trials in Savannah grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (65 active studies)
- A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer · Phase 1 · TerSera Therapeutics LLC
- A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) · Phase 3 · Merck Sharp & Dohme LLC
Mental health & behavior (12 active studies)
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
- REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool · Phase 3 · Senseye, Inc.
Neurology & pain (10 active studies)
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
- Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease · Phase 2 · Celgene
Cardiovascular (9 active studies)
- A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran · Phase 2 · Alnylam Pharmaceuticals
- Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF) · Medtronic Cardiac Ablation Solutions
Diabetes & metabolic (6 active studies)
- A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · Pfizer
- A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus · Phase 2 · Corxel Pharmaceuticals
Vaccines (4 active studies)
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults · Phase 3 · ModernaTX, Inc.
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
Pediatric (1 active study)
Common conditions studied in Savannah
- Major Depressive Disorder (8 active studies). Major depressive disorder research examines rapid-acting agents, augmentation strategies, and digital therapeutics for treatment-resistant cases.
- Breast Cancer (5 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Malignant Solid Neoplasm (5 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage IV Lung Cancer AJCC v8 (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Atopic Dermatitis (4 active studies). Atopic dermatitis studies test IL-13 inhibitors, JAK inhibitors, and next-generation topical therapies for moderate-to-severe eczema.
- Melanoma (4 active studies). Melanoma trials test immune checkpoint inhibitors, adoptive cell therapies, and BRAF/MEK targeted combinations in both early and metastatic disease.
Leading research sponsors in Savannah
- National Cancer Institute (NCI)
- Children's Oncology Group
- SWOG Cancer Research Network
- NRG Oncology
- AbbVie
Local regulations and guidelines
Clinical trials in Georgia are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Georgia research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Savannah. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Savannah
Hipa.ai aggregates every recruiting study in Savannah from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Savannah?
There are approximately 159 recruiting clinical trials in Savannah, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Savannah pay participants?
Most recruiting trials in Savannah compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Savannah?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Savannah?
The most common conditions under active study in Savannah include Major Depressive Disorder (8), Breast Cancer (5), Malignant Solid Neoplasm (5), Stage IV Lung Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Savannah?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Savannah on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Savannah?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Savannah?
Recruiting research sites in Savannah include Memorial Health University Medical Center, Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Low Country Cancer Care, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Savannah right now?
The largest active categories in Savannah are Cancer & tumors (65), Mental health & behavior (12), Neurology & pain (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.